Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b. (Q53226586)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2007

Language	Label	Description	Also known as
English	Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b.	scientific article published in November 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

relapsing-remitting multiple sclerosis

0 references

multiple sclerosis

0 references

Nikos Evangelou

1 reference

ORCID Public Data File 2021

author name string

K Baum

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

C O'Leary

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

F Coret Ferrer

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

E Klímová

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

L Procházková

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

J Bugge

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

BRIGHT Study Group

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

publication date

1 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

13

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

9

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

1153-1160

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1177%2F1352458507079291

21 January 2018

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1177%2F1352458507079291

21 January 2018

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).

1 reference

https://api.crossref.org/works/10.1177%2F1352458507079291

21 January 2018

Managing the adverse effects of interferon-beta therapy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507079291

21 January 2018

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1177%2F1352458507079291

21 January 2018

Cutaneous ulcerations following subcutaneous interferon beta injection to a patient with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507079291

21 January 2018

Local pain during REBIF injection is not due to acidic pH.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507079291

21 January 2018

Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507079291

21 January 2018

Prevalence and impact of depression and pain in neurology outpatients

1 reference

https://api.crossref.org/works/10.1177%2F1352458507079291

21 January 2018

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507079291

21 January 2018

Identifiers

10.1177/1352458507079291

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

release_rxvx3rdkh5b55lcalaahc3x2se

1 reference

https://api.fatcat.wiki/v0/release/rxvx3rdkh5b55lcalaahc3x2se

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/17967843

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53226586&oldid=1842862960"